Effects of Obesity and Thrombophilia on the Risk of Abortion in Women Undergoing
abortion
in vitro fertilization
obesity
pregnancy
thrombophilia
Journal
Frontiers in endocrinology
ISSN: 1664-2392
Titre abrégé: Front Endocrinol (Lausanne)
Pays: Switzerland
ID NLM: 101555782
Informations de publication
Date de publication:
2020
2020
Historique:
received:
14
08
2020
accepted:
19
11
2020
entrez:
11
1
2021
pubmed:
12
1
2021
medline:
22
5
2021
Statut:
epublish
Résumé
Obesity is associated with a higher risk of abortion in women undergoing Patient characteristics, presence of inherited or acquired thrombophilia, and comorbidities were prospectively collected before the procedure in consecutive women undergoing IVF. The primary outcome was the incidence of abortion among women who achieved a clinical pregnancy. A total of 633 non-obese and 49 obese Caucasian women undergoing IVF were included. 204 (32%) women achieved clinical pregnancy, of whom six had an ectopic pregnancy and 63 experienced an abortion. The incidence of abortion was higher in obese women compared to non-obese women after adjusting for age (64.3% vs. 29.3%, odds ratio [OR] 4.41; 95% CI 1.41 to 13.81). Women with one or more thrombophilia were at increased risk of abortion relative to those without thrombophilia (OR 2.70; 95% CI 1.34 to 5.45), and the risk seemed to be higher with hereditary (OR 5.12; 95% CI 1.77 to 14.8) than acquired thrombophilia (OR 1.92; 95% CI 0.52 to 5.12; p for interaction 0.194). Among obese women, the presence of one or more thrombophilia seemed associated with a substantially increased risk of abortion (unadjusted OR 14.00; 95% CI 0.94 to 207.6). Obese women undergoing IVF have a high risk of abortion which seems further amplified by the concomitant presence of thrombophilia.
Identifiants
pubmed: 33424770
doi: 10.3389/fendo.2020.594867
pmc: PMC7786836
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
594867Informations de copyright
Copyright © 2020 Candeloro, Di Nisio, Ponzano, Tiboni, Potere, Tana, Rutjes and Porreca.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
Hum Reprod. 2017 Oct 1;32(10):1957-1973
pubmed: 29117383
Semin Thromb Hemost. 2019 Jul;45(5):555-556
pubmed: 31195417
J Thromb Haemost. 2011 Dec;9(12):2503-6
pubmed: 21985211
Gynecol Endocrinol. 2010 May;26(5):325-32
pubmed: 20192898
Hum Reprod. 2015 Mar;30(3):495-8
pubmed: 25376455
Am J Ther. 2019 May/Jun;26(3):e364-e374
pubmed: 30985485
Hum Reprod Update. 2017 Nov 1;23(6):681-705
pubmed: 28961722
N Engl J Med. 2017 Jul 6;377(1):13-27
pubmed: 28604169
World Health Organ Tech Rep Ser. 1995;854:1-452
pubmed: 8594834
Reprod Health. 2018 Feb 27;15(1):34
pubmed: 29486787
JAMA Cardiol. 2019 Feb 1;4(2):163-173
pubmed: 30649175
Thromb Res. 2018 May 9;167:26-31
pubmed: 29772490
Fertil Steril. 2011 Mar 1;95(3):1042-7
pubmed: 21195401
J Assist Reprod Genet. 2018 Jul;35(7):1289-1294
pubmed: 29679182
Am J Prev Med. 2012 Jun;42(6):563-70
pubmed: 22608371